American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

Neuro-Oncology

Volumn 18, Issue , 2015, Pages i1-i50

  Ostrom, Quinn T ^a,b   Gittleman, Haley ^a,b   De Blank, Peter M ^a,c   Finlay, Jonathan L ^d   Gurney, James G ^e   McKean Cowdin, Roberta ^f   Stearns, Duncan S ^a,c   Wolff, Johannes E ^g   Liu, Max ^h   Wolinsky, Yingli ^a,b   Kruchko, Carol ^b   Barnholtz Sloan, Jill S ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Central Brain Tumor Registry of the United States   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF MEMPHIS   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h Solon High School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCIDENT; ADOLESCENT; ADULT; AGE; ARTICLE; ASTROCYTOMA; BEHAVIOR; BRAIN CANCER; BRAIN REGION; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER STATISTICS; CANCER SURVIVAL; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; EPENDYMOMA; ETHNIC DIFFERENCE; FEMALE; FRONTAL LOBE; GERM CELL TUMOR; GLIOBLASTOMA; GLIOMA; HEALTH INSURANCE; HEALTH STATUS; HISTOPATHOLOGY; HOMICIDE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MENINGIOMA; MIXED GLIOMA; MORBIDITY; OCCIPITAL LOBE; OLIGODENDROGLIOMA; PARIETAL LOBE; PIOCYTIC ASTROCYTOMA; POPULATION RESEARCH; RACE; RISK FACTOR; SEX DIFFERENCE; SUICIDE; SURVIVAL RATE; TEMPORAL LOBE; TIME; TREND STUDY; UNITED STATES; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; EPIDEMIOLOGICAL MONITORING; REGISTER; SURVIVAL ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; EPIDEMIOLOGICAL MONITORING; HUMANS; REGISTRIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84959900894     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nov297     Document Type: Article

References (45)

1. Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat. Rev. Cancer. Apr 2008;8(4):288-298.
2. Tricoli JV, Seibel NL, Blair DG, et al. Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst. Apr 20 2011;103(8):628-635.
3. Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro Oncol. Oct 2015; 17(Suppl 4):iv1-iv62.
4. Ostrom QT, de Blank PM, Kruchko C, et al. Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro Oncol. Jan 2015;16(Suppl 10): x1-x36.
5. Lewis DR, Seibel NL, Smith AW, Stedman MR. Adolescent and young adult cancer survival. J. Natl. Cancer Inst. Monogr. Nov 2014;2014(49):228-235.
6. Howlader N, NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015. 2015.
7. Centers for Disease Control and Prevention National Center for Health Statistics. United States Cancer Statistics: 1999-2012 Incidence, WONDER Online Database. United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2015. Accessed at http://wonder.cdc.gov/cancer-v2012.html. http://wonder.cdc.gov/ucd-icd10.html.
8. Centers for Disease Control and Prevention National Center for Health Statistics. Underlying Cause of Death 1999-2013 on CDC WONDER Online Database, released 2015. Data are fromthe Multiple Cause of Death Files, 1999-2013, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. http://wonder.cdc.gov/ucd-icd10.html.
9. National Cancer Institute. Overview of the SEER Program. http://seer.cancer.gov/about/overview.html.
10. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2012 Incidence and Mortality Web-based Report. 2015; www.cdc.gov/uscs.
11. Surveillance Research Program - National Cancer Institute. SEER ⋯ as a Research Resource. 2010; http://seer.cancer.gov/about/factsheets/SEER-Research-Brochure.pdf.
12. Surveillance Epidemiology and End Results (SEER) Program. Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2010 Census Data). 2015.
13. Surveillance Epidemiology and End Results (SEER) Program. SEER∗Stat Database: Populations - Total U.S. (1990-2013) - Linked To County Attributes - Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released December 2014. http://seer.cancer.gov/popdata/.
14. McCarthy BJ, Surawicz T, Bruner JM, et al. Consensus Conference on Brain Tumor Definition for registration. November 10, 2000. Neuro Oncol. 2002;4(2):134-145. http://www.ncbi.nlm.nih.gov/pubmed/11916506.
15. International Agency for Research on Cancer. International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3). 2000.
16. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. Aug 2007;114(2):97-109.
17. Kleihues P, Burger PC, Scheithauer BW. Histological Classification of Tumours of the Central Nervous System. Histological Typing of Tumours of the Central Nervous System: Springer Berlin Heidelberg; 1993:5-10.
18. R Core Team. R: A language and environment for statistical computing. 2014; http://www.R-project.org/.
19. Surveillance Epidemiology and End Results (SEER) Program. SEER∗Stat software version 8.2.1. 2014; www.seer.cancer.gov/seerstat.
20. Bivand R, Rundel C. rgeos: Interface to Geometry Engine - Open Source (GEOS). R package version 0.3-11. 2015; http://CRAN. R-project.org/package=rgeos.
21. Bivand R, Keitt T, Rowlingson B. rgdal: Bindings for the Geospatial Data Abstraction Library. R package version 1.0-4. 2015; http://CRAN.R-project.org/package=rgdal.
22. Bivand R, Lewin-Koh N. maptools: Tools for Reading and Handling Spatial Objects. R package version 0.8-36. 2015; http://CRAN. R-project.org/package=maptools.
23. Wickham H. ggplot2: elegant graphics for data analysis. 2009; http://had.co.nz/ggplot2/book.
24. Lemon J. Plotrix: a package in the red light district of R. R-News. 2006;6(4):8-12.
25. Luo J. SEER2R: reading and writing SEER∗STAT data files. R package version 1.0. 2012; http://CRAN.R-project.org/package=SEER2R.
26. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Statistical methods in medical research. 2006;15(6):547-569. http://www.ncbi.nlm.nih.gov/pubmed/17260923.
27. NAACCR Race and Ethnicity Work Group. NAACCR Guideline for Enhancing Hispanic/Latino Identification: Revised NAACCR Hispanic/Latino Identification Algorithm [NHIA v2.2.1]. September 2012.
28. Joinpoint Regression Program, Version 4.2.0 - April 2015; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute.
29. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine. Feb 15 2000;19(3):335-351.
30. Zhu L, Pickle LW, Ghosh K, et al. Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence. Cancer. Feb 15 2012;118(4):1100-1109.
31. Surveillance Epidemiology and End Results (SEER) Program. SEER Cause of Death Recode 1969+. http://seer.cancer.gov/codrecode/1969+-d04162012/index.html.
32. Surveillance Epidemiology and End Results (SEER) Program. SEER∗Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (1973-2012 varying) - Linked To County Attributes - Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission.
33. Surveillance Epidemiology and End Results (SEER) Program. DevCan database: "SEER 18 Incidence and Mortality, 2000-2011, with Kaposi Sarcoma and Mesothelioma". National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released August 2014, based on the November 2013 submission. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
34. Surveillance Epidemiology and End Results (SEER) Program. Cancer Survival Statistics: Cohort Definition Using Diagnosis Year. 2010; http://surveillance.cancer.gov/survival/cohort.html.
35. Kleihues P, Cavenee W. Tumours of the nervous system: World Health Organization classification of tumours. Lyon, France: IARC Press; 2000.
36. Niu X, Roche LM, Pawlish KS, Henry KA. Cancer survival disparities by health insurance status. Cancer Med. Jun 2013;2(3):403-411.
37. Bradley CJ, Gardiner J, Given CW, Roberts C. Cancer, Medicaid enrollment, and survival disparities. Cancer. Apr 15 2005;103(8): 1712-1718.
38. Rosenberg AR, Kroon L, Chen L, et al. Insurance status and risk of cancer mortality among adolescents and young adults. Cancer. Apr 15 2015;121(8):1279-1286.
39. Benign Brain Tumor Cancer Registries Amendment Act, 107th Cong. § 260 (2002). http://www.gpo.gov/fdsys/pkg/PLAW-107publ260/pdf/PLAW-107publ260.pdf.
40. McCarthy BJ, Kruchko C, Dolecek TA. The Impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on Non-malignant Brain and Central Nervous System Tumor Incidence Trends. J Registry Manag. Spring 2013;40(1):32-35.
41. Braganza MZ, Kitahara CM, Berrington de Gonzalez A, et al. Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol. Nov 2012; 14(11):1316-1324.
42. Turner MC. Epidemiology: allergy history, IgE, and cancer. Cancer Immunol. Immunother. Sep 2012;61(9):1493-1510.
43. Ostrom QT, Bauchet L, Davis F, et al. The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol. 2014;16(7): 896-913.
44. Johnson KJ, Cullen J, Barnholtz-Sloan JS, et al. Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review. Cancer Epidemiol Biomarkers Prev. Sep 5 2014.
45. Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. Journal of neurooncology. Sep 2010;99(3):307-314.